See more : Novavis Group S.A. (NVG.WA) Income Statement Analysis – Financial Results
Complete financial analysis of Endava plc (DAVA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Endava plc, a leading company in the Software – Infrastructure industry within the Technology sector.
You may be interested
- Yantai China Pet Foods Co., Ltd. (002891.SZ) Income Statement Analysis – Financial Results
- Block, Inc. (SQ2.AX) Income Statement Analysis – Financial Results
- Logan Group Company Limited (3380.HK) Income Statement Analysis – Financial Results
- GFL Environmental Inc. (GFL.TO) Income Statement Analysis – Financial Results
- Sanara MedTech Inc. (SMTI) Income Statement Analysis – Financial Results
Endava plc (DAVA)
About Endava plc
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in Europe, Latin America, North America, and internationally. The company offers technology and digital advisory services for payments and financial services, and TMT sectors; IT strategies; business analysis services; program management services; digital product strategy services; and architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services. It also engages in the identifying, defining, and embedding collaborative data and analytics; and provision of automated testing, cloud native software engineering, continuous delivery, distributed agile delivery, intelligent automation, secure development, agile applications management, cloud infrastructure, DevSecOps, service delivery, smart desk, and telemetry and monitoring services. The company was founded in 2000 and is headquartered in London, the United Kingdom.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 740.76M | 794.73M | 654.76M | 446.30M | 350.95M | 287.93M | 217.61M | 159.37M | 115.43M | 84.11M | 63.91M | 42.61M |
| Cost of Revenue | 561.05M | 530.66M | 436.83M | 292.47M | 250.80M | 189.10M | 145.44M | 108.76M | 75.05M | 52.28M | 42.18M | 28.16M |
| Gross Profit | 179.71M | 264.08M | 217.93M | 153.83M | 100.15M | 98.83M | 72.17M | 50.61M | 40.39M | 31.83M | 21.73M | 14.44M |
| Gross Profit Ratio | 24.26% | 33.23% | 33.28% | 34.47% | 28.54% | 34.32% | 33.16% | 31.76% | 34.99% | 37.84% | 34.01% | 33.90% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 135.30M | 0.00 | 0.00 | 78.28M | 65.86M | 0.00 | 0.00 | 0.00 | 180.00K | 150.00K | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 433.00K | 333.00K | 0.00 |
| SG&A | 159.57M | 135.30M | 121.81M | 90.29M | 78.28M | 65.86M | 46.74M | 27.55M | 20.45M | 613.00K | 483.00K | 167.36K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -49.00K | -5.95M | 46.74M | 27.55M | 20.45M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 159.57M | 150.30M | 121.81M | 90.29M | 78.28M | 65.86M | 46.74M | 27.55M | 20.45M | 16.57M | 12.02M | 9.81M |
| Cost & Expenses | 720.62M | 680.96M | 558.63M | 382.76M | 329.08M | 254.96M | 192.18M | 136.31M | 95.50M | 68.85M | 54.20M | 37.98M |
| Interest Income | 6.19M | 3.90M | 188.00K | 104.00K | 555.00K | 486.00K | 35.00K | 18.00K | 1.07M | 56.00K | 29.00K | 94.13K |
| Interest Expense | 6.27M | 1.95M | 1.51M | 1.59M | 1.08M | 345.00K | 818.00K | 408.00K | 170.00K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 38.94M | 32.93M | 28.97M | 24.45M | 18.25M | 7.90M | 6.27M | 4.35M | 2.88M | 1.27M | 1.22M | 1.25M |
| EBITDA | 72.19M | 150.77M | 96.86M | 81.27M | 19.66M | 38.35M | 31.49M | 27.42M | 23.88M | 18.38M | 11.18M | 6.17M |
| EBITDA Ratio | 9.75% | 16.32% | 14.79% | 14.24% | 5.60% | 11.45% | 11.69% | 17.21% | 20.69% | 21.85% | 17.50% | 14.49% |
| Operating Income | 20.14M | 112.85M | 67.89M | 38.40M | 932.00K | 33.11M | 25.43M | 23.06M | 19.93M | 17.11M | 9.97M | 4.92M |
| Operating Income Ratio | 2.72% | 14.20% | 10.37% | 8.60% | 0.27% | 11.50% | 11.69% | 14.47% | 17.27% | 20.34% | 15.60% | 11.55% |
| Total Other Income/Expenses | 6.84M | -7.21M | 7.00M | -9.20M | 5.28M | -2.87M | -783.00K | -1.36M | 898.00K | -1.90M | -282.00K | -384.97K |
| Income Before Tax | 26.98M | 114.16M | 102.38M | 54.36M | 25.26M | 30.10M | 24.65M | 21.70M | 20.83M | 15.21M | 9.69M | 4.54M |
| Income Before Tax Ratio | 3.64% | 14.36% | 15.64% | 12.18% | 7.20% | 10.45% | 11.33% | 13.62% | 18.05% | 18.08% | 15.15% | 10.64% |
| Income Tax Expense | 9.86M | 20.00M | 19.29M | 10.91M | 3.85M | 6.09M | 5.68M | 4.87M | 4.13M | 1.66M | 1.54M | 211.34K |
| Net Income | 17.12M | 94.16M | 83.09M | 43.45M | 19.99M | 24.01M | 18.98M | 16.83M | 16.71M | 13.55M | 8.15M | 4.75M |
| Net Income Ratio | 2.31% | 11.85% | 12.69% | 9.74% | 5.70% | 8.34% | 8.72% | 10.56% | 14.47% | 16.11% | 12.75% | 11.14% |
| EPS | 0.29 | 1.62 | 1.48 | 0.79 | 0.40 | 0.44 | 0.38 | 0.32 | 0.32 | 0.29 | 0.16 | 0.12 |
| EPS Diluted | 0.29 | 1.62 | 1.43 | 0.76 | 0.38 | 0.44 | 0.38 | 0.32 | 0.32 | 0.29 | 0.16 | 0.12 |
| Weighted Avg Shares Out | 58.44M | 57.31M | 56.27M | 55.22M | 53.42M | 54.56M | 49.80M | 53.00M | 53.00M | 46.71M | 49.68M | 39.75M |
| Weighted Avg Shares Out (Dil) | 58.80M | 58.08M | 58.02M | 57.05M | 56.07M | 55.03M | 49.80M | 53.00M | 53.00M | 46.81M | 49.86M | 39.75M |
Undercovered Dozen: Endava, Cross Country Healthcare, Cybin, Equinor +
The 'Undercovered' Dozen highlights 12 lesser-covered stocks from October 11th - 17th, aiming to inspire discussion and provide investment ideas. AST SpaceMobile is highly volatile but has strong potential in satellite broadband services according to Josh Arnold who initiated a...
DAVA Deadline: RLF Urges Endava plc (NYSE: DAVA) Stockholders to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Endava plc (NYSE: DAVA) between May 23, 2023 and February 28, 2024....
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Endava, plc (DAVA)
LOS ANGELES, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 25, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or...
DAVA Investors Have Opportunity to Lead Endava plc Securities Fraud Lawsuit
NEW YORK , Oct. 17, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Endava plc (NYSE: DAVA) between May 23, 2023 and February 28, 2024, both dates inclusive (the "Class Period"),...
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Endava plc Investors to Secure Counsel Before Important October 25 Deadline in Securities Class Action – DAVA
NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Endava plc (NYSE: DAVA) between May 23, 2023 and February 28, 2024, both dates inclusive (the “Class Period”),...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Endava plc - DAVA
NEW YORK , Oct. 17, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Endava plc ("Endava" or the "Company") (NYSE: DAVA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free,...
DAVA Investors Have Opportunity to Lead Endava, plc Securities Fraud Lawsuit
BENSALEM, Pa. , Oct. 17, 2024 /PRNewswire/ -- Law Offices of Howard G.
DAVA LAWSUIT ALERT: The Gross Law Firm Notifies Endava plc Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK , Oct. 17, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Endava plc (NYSE: DAVA). Shareholders who purchased shares of DAVA during the class period listed are encouraged to contact the firm regarding...
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 25, 2024 in Endava Lawsuit - DAVA
NEW YORK, NY / ACCESSWIRE / October 16, 2024 / If you suffered a loss on your Endava plc (NYSE:DAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more...
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Endava
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Endava To Contact Him Directly To Discuss Their Options
Source: https://incomestatements.info
Category: Stock Reports